India Corona Vaccine latest news: The Coronavirus vaccine ‘Covaxin’ which is being tested by Bharat Biotech Ltd in collaboration with the Indian Council of Medical Research (ICMR) will be tested for its phase-3 trials in Uttar Pradesh’s Lucknow and Gorakhpur.Also Read - Tested Positive For Omicron? Follow These Home Isolation Guidelines

Additional Chief Secretary (Medical and Health) Amit Mohan Prasad conveyed the Uttar Pradesh’s government’s permission to test the anti-COVID-19 vaccine in the two cities through a letter to Bharat Biotech International Limited’s director V Krishna Mohan. Also Read - Singapore Shuttler Yeo Jia Min Tests COVID Positive on Return From India

“Kindly refer to your letter dated September 19, 2020 for permission and facilitation to initiate the COVAXIN Phase 3 Efficacy and Safety clinical trials in Uttar Pradesh. It has been decided to allow Bharat Biotech to conduct Phase-3 trial in Lucknow and Gorakhpur,” Prasad said in his letter. Also Read - Omicron Variant: How Excessive Intake of Immunity Supplements Can Affect Your Body Organs

“All permission will have to be obtained by you and all safety and other protocols will have to be followed as per the guidelines of the Government of India for conducting clinical trials,” he added in the letter.

For Lucknow, Dr R K Dhiman, the director of Sanjay Gandhi Post Graduate Institute of Medical Sciences has been made the nodal person, while for Gorakhpur, Dr Ganesh Kumar, the Principal of BRD Medical College has been made the nodal officer.

(With agency inputs)